Sarcoidosis vasculitis and diffuse lung diseases

Published: 2010-06-01

Editorial

Sarcoidosis requiring systemic treatment: why not a steroid-sparing regimen up-front?

N. Sweiss, H. Yeager
Abstract 71 | PDF (Italiano) Downloads 49

Page 3-4

Review

Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis

M. Chilosi, C. Doglioni, B. Murer, et al.
Abstract 238 | PDF (Italiano) Downloads 98

Page 7-18

Original Articles: Clinical Research

Is tobacco smoking protective for sarcoidosis? A case-control study from North India

D. Gupta, A.D. Singh, R. Agarwal, et al.
Abstract 137 | PDF (Italiano) Downloads 64

Page 19-26

Perceptions and beliefs in sarcoidosis

J. Ireland, M. Wilsher
Abstract 138 | PDF (Italiano) Downloads 54

Page 36-42

Minimally invasive diagnosis of sarcoidosis by EBUS when conventional diagnosis fail

J. Eckardt, K.E. Olsen, O.D. Jørgensen
Abstract 117 | PDF (Italiano) Downloads 59

Page 43-48

C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis

N.J. Sweiss, E.S. Barnathan, K. Lo
Abstract 128 | PDF (Italiano) Downloads 63

Page 49-56

Original Articles: Laboratory Research

Cathepsin-K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitis

D. Reghellin, V. Poletti, S. Tomassetti, et al.
Abstract 158 | PDF (Italiano) Downloads 41

Page 57-63

CD24 gene exon 2 dimorphism does not affect disease susceptibility in Japanese sarcoidosis patients

K. Tanizawa, T. Handa, S. Nagai, et al.
Abstract 87 | PDF (Italiano) Downloads 35

Page 64-69

Cytokine gene polymorphisms in sarcoidosis

M. Vasakova, M. Sterclova, L. Kolesar, et al.
Abstract 85 | PDF (Italiano) Downloads 33

Page 70-75

Case Reports